Global Microtome Market (2022 to 2027) - Growing Focus on Personalized Medicine Presents Opportunities

News provided by

May 25, 2022, 11:00 ET

DUBLIN, May 25, 2022 /PRNewswire/ -- The "Global Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades)), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End-user (Hospital, Clinical Labs), and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The microtomes market is projected to reach USD 585.2 million by 2027 from USD 425.4 million in 2022, at a CAGR of 6.6%.

Some of the key factors driving the growth of this market include the high prevalence of cancer, growing demand for digital pathology, and the increasing healthcare expenditure. In addition, the growing focus on personalized medicine and the untapped growth potential of emerging economies are expected to offer growth opportunities for players operating in the microtomes market. However, a lack of skilled professionals to operate microtomes is a key challenge for the growth of this market.

Based on end user the market is classified into hospital laboratories, clinical laboratories, and other end-users. The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals.

Microtome instruments in the product segment to witness the highest shares during the forecast period

Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibrating Microtomes, Other Microtomes, and Microtome Accessories. The microtome instruments segment is expected to dominate the microtome market. High expenditure on microtome instruments and their essential use in the histological diagnosis of various diseases are the key factors driving the growth of the automated microtome market.

Asia Pacific is estimated to register the highest CAGR during the forecast period

In this report, the microtome market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising disposable income of the middle-class population, infrastructural developments, and the rising penetration of diagnostic technologies in Asian countries such as India and China in addition, the rising incidence of cancer and the growing focus of global medical device companies on expanding their presence in emerging Asia Pacific countries are some of the key factors.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Microtomes Market Overview
4.2 Microtomes Market, by Product
4.3 Asia-Pacific: Microtomes Market, by Product and Country
4.4 Geographic Snapshot of Microtomes Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Cancer
5.2.1.2 Growing Demand for Digital Pathology
5.2.1.3 Recommendations for Cancer Screening
5.2.1.4 Availability of Reimbursement
5.2.2 Challenges
5.2.2.1 Lack of Skilled Professionals
5.2.2.2 Availability of Refurbished Products
5.2.3 Opportunities
5.2.3.1 Growing Focus on Personalized Medicine
5.2.3.2 Emerging Economies
5.3 Impact of COVID-19 on Microtomes Market
5.4 Ranges/Scenarios
5.4.1 Microtomes Market
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Technology Analysis
5.8 Porter's Five Forces Analysis
5.9 Key Stakeholders & Buying Criteria
5.9.1 Key Stakeholders in Buying Process
5.9.2 Buying Criteria
5.10 Regulatory Landscape
5.11 Patent Analysis
5.12 Key Conferences & Events in 2022
5.13 Pricing Analysis
5.14 Trade Analysis
5.15 Ecosystem Analysis
5.15.1 Role in Ecosystem
5.15.2 Key Players Operating in Microtomes Market
5.16 Trends/Disruptions Impacting Customers' Businesses

6 Microtomes Market, by Product
6.1 Introduction
6.2 Microtome Instruments
6.2.1 Rotary Microtomes
6.2.1.1 Rotary Microtomes are Widely Used in Histology Laboratories
6.2.2 Cryostat Microtomes
6.2.2.1 Cryostat Microtomes Provide Immediate Results by Quickly, Reliably, and Safely Cutting Accurate Frozen Sections
6.2.3 Vibrating Microtomes
6.2.3.1 Vibrating Microtomes are Designed to Cut Fresh Tissue Specimens
6.2.4 Other Microtomes
6.3 Microtome Accessories
6.3.1 Microtome Blades
6.3.1.1 Adoption of Disposable Blades Has Increased Among End-users
6.3.2 Other Microtome Accessories

7 Microtomes Market, by Technology
7.1 Introduction
7.2 Manual Microtomes
7.2.1 Lower Cost and User Comfort Associated with These Microtomes are Driving Their Adoption
7.3 Semi-Automated Microtomes
7.3.1 Semi-Automated Microtomes Segment to Register Highest Growth Rate During Forecast Period
7.4 Fully Automated Microtomes
7.4.1 Lack of Clinical Laboratory Technicians and High Prevalence of Cancer Have Driven Segment Growth

8 Microtomes Market, by Application
8.1 Introduction
8.2 Disease Diagnosis
8.2.1 Expanding Pool of Geriatric Patients and Increasing Diagnosis of Chronic Diseases Driving Segment Growth
8.3 Medical Research
8.3.1 Increasing Research Activities to Drive Adoption of Microtomes

9 Microtomes Market, by End-user
9.1 Introduction
9.2 Hospital Laboratories
9.2.1 Hospital Laboratories Accounted for Largest Market Share in 2021
9.3 Clinical Laboratories
9.3.1 Presence of Robust Infrastructure to Perform Tests in High Volumes is Estimated to Drive Market Growth
9.4 Other End-users

10 Microtomes Market, by Region

11 Competitive Landscape
11.1 Overview
11.2 Key Player Strategies/Right to Win
11.3 Market Share Analysis
11.4 Company Evaluation Matrix
11.4.1 Stars
11.4.2 Emerging Leaders
11.4.3 Pervasive Players
11.4.4 Participants
11.5 Company Evaluation Matrix for SMEs/Start-Ups
11.5.1 Progressive Companies
11.5.2 Starting Blocks
11.5.3 Responsive Companies
11.5.4 Dynamic Companies
11.6 Company Footprint Analysis
11.7 Competitive Benchmarking
11.8 Competitive Scenario
11.8.1 Product Launches
11.8.2 Deals
11.8.3 Other Developments

12 Company Profiles
12.1 Key Players
12.1.1 Danaher Corporation
12.1.2 PHC Holdings Corporation
12.1.3 Cardinal Health
12.1.4 Boeckeler Instruments, Inc.
12.1.5 Bright Instruments Ltd.
12.1.6 Erma Inc.
12.1.7 Histo-Line Laboratories
12.1.8 Jinhua Yidi Medical Appliance Co. Ltd.
12.1.9 Medimeas
12.1.10 Medite Medical GmbH
12.1.11 Microtec Laborgerate GmbH
12.1.12 Sakura Finetek Usa, Inc.
12.1.13 Slee Medical GmbH
12.1.14 SM Scientific Instruments Pvt. Ltd.
12.1.15 Ted Pella, Inc.
12.2 Other Players
12.2.1 AGD Biomedicals Pvt. Ltd.
12.2.2 Amos Scientific Pty Ltd.
12.2.3 Campden Instruments Ltd.
12.2.4 Diapath S.p.A.
12.2.5 Laboid International
12.2.6 Lafayette Instrument Company
12.2.7 Lupetec
12.2.8 Milestone Medical
12.2.9 RWD Life Science Co. Ltd.
12.2.10 Shenzhen Dakewei Biotechnology Co. Ltd.